The total return over the past 12 months is -42.18% vs. +16.94% for the S&P 500. So far it's up -29.46% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (42.18%) | (30.71%) | (30.65%) | N/A | N/A | N/A |
| Total Return CAGR | (42.18%) | (30.71%) | (30.65%) | N/A | N/A | N/A |
| Revenue CAGR | +55.22% | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
ProKidney Corp. (PROK)
| Year | Start price | End price | PROK Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $2.24 | $1.58 | (29.46%) | +14.51% | (43.97%) |
| 2025 | $1.69 | $2.24 | +32.54% | +17.72% | +14.82% |
| 2024 | $1.78 | $1.69 | (5.06%) | +24.89% | (29.95%) |
| 2023 | $6.86 | $1.78 | (74.05%) | +26.19% | (100.24%) |
| 2022 | $9.90 | $6.86 | (30.71%) | (18.17%) | (12.54%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
